Publication | Closed Access

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

HepatologyGastrointestinal OncologyMedicineColorectal CancerPathologySecondary ResectabilityLiver CancerPhase 2OncologyRadiation OncologyNeoadjuvant Chemotherapy